Stocks and Investing
Stocks and Investing
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
Jeff Johnson Maintained (TNDM) at Hold with Increased Target to $39 on, Aug 2nd, 2024
Jeff Johnson of Baird, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Increased Target from $36 to $39 on, Aug 2nd, 2024.
Jeff has made no other calls on TNDM in the last 4 months.
There are 7 other peers that have a rating on TNDM. Out of the 7 peers that are also analyzing TNDM, 0 agree with Jeff's Rating of Hold.
These are the ratings of the 7 analyists that currently disagree with Jeff
- Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $58 on, Monday, June 10th, 2024
- Issie Kirby of "Redburn Atlantic" Initiated at Strong Buy and Held Target at $60 on, Thursday, May 30th, 2024
- Mathew Blackman of "Stifel" Maintained at Strong Buy with Increased Target to $60 on, Wednesday, May 29th, 2024
- Joanne Wuensch of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $57 on, Wednesday, May 22nd, 2024
- Brooks O'Neil of "Lake Street" Maintained at Strong Buy with Increased Target to $75 on, Wednesday, May 22nd, 2024
- Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $55 on, Monday, May 6th, 2024
- Mike Kratky of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $45 on, Thursday, April 25th, 2024
Contributing Sources